FAR1P1

Across TCGA pan-cancer cohorts, FAR1P1 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated FAR1P1 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher FAR1P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAR1P1 expression acts as an unfavorable survival marker, although some lineages such as BRCA and READ show a favorable association.

UVM, MESO, and LIHC are the cancer types where FAR1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.037	0.858	<.001	108	view →
MESO	OS	Tertile	All	0.149	0.563	.001	63	view →
LIHC	DFS	Tertile	All	0.195	0.454	<.001	45	view →
KIRC	DFS	Tertile	All	0.751	0.895	.001	36	view →
LUAD	OS	Tertile	II,III,IV	0.515	0.776	.003	36	view →
BRCA	OS	Tertile	III,IV	1.000	0.810	.010	36	view →
KIRP	OS	Tertile	II,III,IV	0.111	0.769	<.001	36	view →
COAD	OS	Tertile	IV	0.082	0.659	<.001	36	view →
UCS	OS	Tertile	II,III,IV	0.207	0.543	.028	36	view →
SKCM	OS	Tertile	All	0.601	0.798	.004	33	view →
STAD	DFS	Median	IV	0.201	0.542	.011	21	view →
SARC	OS	Tertile	All	0.599	0.847	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

FAR1P1–UVM (OS)

Open the UVM breakdown →